Targeted delivery and transcription of genes encoding critical regulators in bone remodelling including BMPs, PTH or OPG has proven efficient to treat experimental osteoporosis [59,60,61,62,63,64,65,66,67]. This evidence concerns the gene PTH and osteoporosis.